These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3481387)

  • 1. The effect of renal function on the pharmacokinetics of gemfibrozil.
    Evans JR; Forland SC; Cutler RE
    J Clin Pharmacol; 1987 Dec; 27(12):994-1000. PubMed ID: 3481387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flecainide pharmacokinetics after multiple dosing in patients with impaired renal function.
    Forland SC; Cutler RE; McQuinn RL; Kvam DC; Miller AM; Conard GJ; Parish S
    J Clin Pharmacol; 1988 Aug; 28(8):727-35. PubMed ID: 3145942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gas chromatographic determination of gemfibrozil and its metabolites in plasma and urine.
    Randinitis EJ; Kinkel AW; Nelson C; Parker TD
    J Chromatogr; 1984 Apr; 307(1):210-5. PubMed ID: 6586728
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2C8 activity recovers within 96 hours after gemfibrozil dosing: estimation of CYP2C8 half-life using repaglinide as an in vivo probe.
    Backman JT; Honkalammi J; Neuvonen M; Kurkinen KJ; Tornio A; Niemi M; Neuvonen PJ
    Drug Metab Dispos; 2009 Dec; 37(12):2359-66. PubMed ID: 19773535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of gemfibrozil and atorvastatin on the pharmacokinetics of repaglinide in relation to SLCO1B1 polymorphism.
    Kalliokoski A; Backman JT; Kurkinen KJ; Neuvonen PJ; Niemi M
    Clin Pharmacol Ther; 2008 Oct; 84(4):488-96. PubMed ID: 19238654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone.
    Jaakkola T; Backman JT; Neuvonen M; Neuvonen PJ
    Clin Pharmacol Ther; 2005 May; 77(5):404-14. PubMed ID: 15900286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemfibrozil for secondary prevention of cardiovascular events in mild to moderate chronic renal insufficiency.
    Tonelli M; Collins D; Robins S; Bloomfield H; Curhan GC;
    Kidney Int; 2004 Sep; 66(3):1123-30. PubMed ID: 15327407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of gemfibrozil on the pharmacokinetics of pioglitazone.
    Deng LJ; Wang F; Li HD
    Eur J Clin Pharmacol; 2005 Dec; 61(11):831-6. PubMed ID: 16283275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemfibrozil increases plasma pravastatin concentrations and reduces pravastatin renal clearance.
    Kyrklund C; Backman JT; Neuvonen M; Neuvonen PJ
    Clin Pharmacol Ther; 2003 Jun; 73(6):538-44. PubMed ID: 12811363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of glimepiride.
    Niemi M; Neuvonen PJ; Kivistö KT
    Clin Pharmacol Ther; 2001 Nov; 70(5):439-45. PubMed ID: 11719730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of gemfibrozil and fenofibrate on the pharmacokinetics of atorvastatin.
    Whitfield LR; Porcari AR; Alvey C; Abel R; Bullen W; Hartman D
    J Clin Pharmacol; 2011 Mar; 51(3):378-88. PubMed ID: 20413454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some comparative effects of gemfibrozil, clofibrate, bezafibrate, cholestyramine and compactin on sterol metabolism in rats.
    Maxwell RE; Nawrocki JW; Uhlendorf PD
    Atherosclerosis; 1983 Sep; 48(3):195-203. PubMed ID: 6579963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemfibrozil considerably increases the plasma concentrations of rosiglitazone.
    Niemi M; Backman JT; Granfors M; Laitila J; Neuvonen M; Neuvonen PJ
    Diabetologia; 2003 Oct; 46(10):1319-23. PubMed ID: 12898007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of renal insufficiency and haemodialysis on the kinetics of ciprofibrate.
    Ferry N; Bernard N; Pozet N; Gardes E; Cuisinaud G; Labeeuw M; Zech PY; Sassard J
    Br J Clin Pharmacol; 1989 Dec; 28(6):675-81. PubMed ID: 2611089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a single gemfibrozil dose on the pharmacokinetics of rosuvastatin in bile and plasma in healthy volunteers.
    Bergman E; Matsson EM; Hedeland M; Bondesson U; Knutson L; Lennernäs H
    J Clin Pharmacol; 2010 Sep; 50(9):1039-49. PubMed ID: 20150523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of gemfibrozil on serum lipids in man.
    Fenderson RW; Deutsch S; Menachemi E; Chin B; Samuel P
    Angiology; 1982 Sep; 33(9):581-93. PubMed ID: 6751166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of gemfibrozil in plasma by high performance liquid chromatography.
    Hengy H; Kölle EU
    Arzneimittelforschung; 1985; 35(11):1637-9. PubMed ID: 3867353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of racemic warfarin in healthy subjects.
    Lilja JJ; Backman JT; Neuvonen PJ
    Br J Clin Pharmacol; 2005 Apr; 59(4):433-9. PubMed ID: 15801938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of the effect of Gemfibrozil on some haematological parameters.
    O'Brien JR; Etherington MD; Shuttleworth RD; Adams CM; Middleton JE; Goodland FC
    Thromb Res; 1982 May; 26(4):275-9. PubMed ID: 6955993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.